These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 3699340)

  • 21. A symptomatological assessment of organophosphate-induced lethality in mice: comparison of atropine and clonidine protection.
    Liu WF
    Toxicol Lett; 1991 Apr; 56(1-2):19-32. PubMed ID: 2017778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarin.
    Bueters TJ; Joosen MJ; van Helden HP; Ijzerman AP; Danhof M
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1307-13. PubMed ID: 12604711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QTc prolongation and cardiac lesions following acute organophosphate poisoning in rats.
    Abraham S; Oz N; Sahar R; Kadar T
    Proc West Pharmacol Soc; 2001; 44():185-6. PubMed ID: 11793977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiorespiratory function in nerve agent poisoned and oxime + atropine treated guinea-pigs: effect of pyridostigmine pretreatment.
    Worek F; Szinicz L
    Arch Toxicol; 1995; 69(5):322-9. PubMed ID: 7654137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Organophosphate-induced convulsions and prevention of neuropathological damages.
    Tuovinen K
    Toxicology; 2004 Mar; 196(1-2):31-9. PubMed ID: 15036754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of pyridostigmine on tetanic contracture of innervated and denervated rat skeletal muscle.
    Anderson RJ
    Neurotoxicology; 1987; 8(4):553-60. PubMed ID: 3441318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral acetylcholine and choline contents and turnover following low-dose acetylcholinesterase inhibitors treatment in rats.
    Shih TM; Scremin OU; Roch M; Huynh L; Sun W; Jenden DJ
    Arch Toxicol; 2006 Nov; 80(11):761-7. PubMed ID: 16628397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection from quinidine or physostigmine against in vitro inhibition by sarin of acetylcholinesterase activity.
    Singh AK; Zeleznikar RJ; Drewes LR
    Life Sci; 1986 Jan; 38(2):165-72. PubMed ID: 3945161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pyridostigmine and syntostigmine pretreatment on the inhibition of acetylcholinesterases by o-pinacolyl-methylphosphonofluoridate. In vitro experiments with rat tissues.
    Patocka J
    Biomed Biochim Acta; 1989; 48(9):715-20. PubMed ID: 2619740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamine.
    Harris L; Stitcher D
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):64-9. PubMed ID: 6493352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of carbamates, atropine, and 2-pyridine aldoxime methoiodide in the protection of Artemia salina against poisoning by carbophenothion.
    Sánchez-Fortún S; Barahona V
    Environ Toxicol Chem; 2001 Sep; 20(9):2008-13. PubMed ID: 11521828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine.
    Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Nagelkerke N
    Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):235-40. PubMed ID: 17056080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensorimotor deficit and cholinergic changes following coexposure with pyridostigmine bromide and sarin in rats.
    Abou-Donia MB; Dechkovskaia AM; Goldstein LB; Bullman SL; Khan WA
    Toxicol Sci; 2002 Mar; 66(1):148-58. PubMed ID: 11861982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of blood cholinesterase levels with toxicity of sarin in rats.
    Young JF; Gough BJ; Suber RL; Gaylor DW
    J Toxicol Environ Health A; 2001 Feb; 62(3):161-74. PubMed ID: 11212943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacy of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) against organophosphate intoxication.
    Bueters TJ; Groen B; Danhof M; IJzerman AP; Van Helden HP
    Arch Toxicol; 2002 Nov; 76(11):650-6. PubMed ID: 12415428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of poisoning by soman.
    Leadbeater L; Inns RH; Rylands JM
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S225-31. PubMed ID: 4092890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure.
    Solana RP; Gennings C; Carter WH; Anderson D; Lennox WJ; Carchman RA; Harris LW
    Fundam Appl Toxicol; 1990 Nov; 15(4):814-9. PubMed ID: 2086320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine.
    Petroianu GA; Hasan MY; Nurulain SM; Shafiullah M; Sheen R; Nagelkerke N
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):312-6. PubMed ID: 17040217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eptastigmine-phosphotriesterase combination in DFP intoxication.
    Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):364-9. PubMed ID: 8887453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning.
    Levy A; Cohen G; Gilat E; Kapon J; Dachir S; Abraham S; Herskovitz M; Teitelbaum Z; Raveh L
    Arch Toxicol; 2007 May; 81(5):353-9. PubMed ID: 17009047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.